IDH1 and central nervous system cancer: IDH1 wildtype status has been associated with poor survival outcome regardless of WHO grade.30 Furthermore, aggressive surgical tumor resection has not been shown to provide survival benefit, specifically in IDH1 wildtype gliomas.31 Therefore, preoperative identification of IDH1 status can play an important role with prognostic and treatment implications.